Table 2. mRNA expression determined by Q-RT-PCR for a number of nuclear-encoded mitochondrial genes and NEFA oxidation genes.
Gene | Nutritional therapy | Pioglitazone | p valuea | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
||||||||
Before | After | Fold change | p value | Before | After | Fold change | p value | ||
ACADM | 3.01 ±0.83 | 3.27±1.11 | 1.08 | NS | 4.37±1.54 | 8.22±1.88 | 1.88 | 0.0067 | 0.022 |
HADH | 0.39±0.08 | 0.39±0.09 | 1.01 | NS | 0.39±0.10 | 0.84±0.11 | 2.18 | 0.000023 | 0.0041 |
COX6C | 1.26±0.27 | 1.44±0.39 | 1.14 | NS | 1.40±0.45 | 2.18±0.47 | 1.56 | 0.000038 | NS |
CPT1B | 0.31±0.05 | 0.32±0.08 | 1.00 | NS | 0.43±0.13 | 0.77±0.19 | 1.76 | 0.012 | 0.040 |
CREB1 | 0.30±0.06 | 0.38±0.09 | 1.26 | NS | 0.33±0.10 | 0.54±0.09 | 1.63 | 0.011 | NS |
IDH3B | 1.25±0.29 | 1.29±0.46 | 1.04 | NS | 1.26±0.39 | 1.88±0.33 | 1.48 | 0.0073 | NS |
MEF2C | 0.68±0.24 | 0.69±0.20 | 1.02 | NS | 0.91 ±0.21 | 1.18±0.18 | 1.30 | 0.020 | NS |
NDUFA5 | 1.09±0.20 | 1.02±0.27 | 0.93 | NS | 1.46±0.43 | 2.28±0.50 | 1.56 | 0.00040 | 0.0017 |
NQO1 | 0.87±0.20 | 0.90±0.25 | 1.03 | NS | 0.51±0.23 | 2.77±1.16 | 5.4 | NS | 0.018 |
PPARA | 0.99±0.24 | 0.64±0.13 | 0.65 | NS | 0.81±0.25 | 1.16±0.18 | 1.43 | 0.00096 | 0.019 |
PPARD | 1.15±0.07 | 1.19±0.31 | 1.03 | NS | 0.81 ±0.27 | 1.02±0.22 | 1.26 | NS | NS |
PPARG | 0.24±0.05 | 0.31 ±0.11 | 1.27 | NS | 0.32±0.09 | 0.47±0.08 | 1.56 | 0.0020 | NS |
SIRT1 | 0.35±0.09 | 0.28±0.06 | 0.80 | NS | 0.26±0.08 | 0.36±0.06 | 1.36 | 0.0032 | NS |
SOD2 | 0.039±0.016 | 0.027±0.009 | 0.69 | NS | 0.022±0.006 | 0.054±0.009 | 2.4 | 0.0069 | 0.0091 |
Values are means±SEM
p value (ANOVA) for the comparison between pioglitazone- and nutritional therapy-treated groups (change from baseline)